Stockreport

Cue Biopharma (NASDAQ:CUE) adds US$31m to market cap in the past 7 days, though investors from three years ago are still down 89% [Yahoo! Finance]

Cue Biopharma, Inc.  (CUE) 
US:NASDAQ Investor Relations: cuebiopharma.gcs-web.com/news-releases
PDF NASDAQ:CUE ) up an impressive 135%. But that is meagre solace in the face of the shocking decline over three years. The share price has sunk like a leaky ship, down 89% [Read more]